Amarin Corporation plc (AMRN)

NASDAQ: AMRN · USD

$12.7

+0.74 (+6.2%)· Recorded snapshot

Market cap	268M
Revenue (ttm)	176.1M
Net income (ttm)	-19.1M
EPS (ttm)	-$0.91
Shares out	21.1M
Volume	155,498
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 176.1M
Net income (ttm): -19.1M
EPS (ttm): -$0.91
Market cap: 268M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-4.2

P25 n/aP50 n/aP75 n/a

ROIC-18.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AMRN indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000897448
Company name	Amarin Corporation plc
Country	Ireland
Country code	US
CUSIP number	023111404
Earnings date	2026-10-28
Earnings time	bmo
Employees	80
Employees change	-195
Employees growth	-70.91%
Enterprise value	$-50M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1989
Industry	Drug Manufacturers - General
IPO date	1993-04-01
Is primary listing	Yes
Is SPAC	No
ISIN number	US0231114044
Last 10-K release date	2026-03-02
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2025-04-11
Last stock split type	Reverse
Market cap	$268M
Market cap category	Micro-Cap
Next earnings date	2027-02-24
Options	Yes
Price	$12.69
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AMRN
Website	https://www.amarincorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.2%
FCF / EV yield	-74.55%
FCF yield	14%
Forward P/S	1.55x
Industry forward P/E	18.47x
Industry P/E	35.8x
P/(FCF - SBC) ratio	8.9x
P/(OCF - SBC) ratio	8.9x
P/B ratio	0.57x
P/FCF ratio	7.14x
P/OCF ratio	7.14x
P/S ratio	1.52x
Price / tangible book value	0.62x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-13.97%
EBITDA margin	-12.48%
FCF margin	21.29%
Gross margin	40.94%
Operating margin	-13.97%
Pretax margin	-9.73%
Profit margin	-10.87%
Profit per employee	$-239,263
Revenue per employee	$2.2M
ROA	-2.38%
ROA (5Y)	-2.07%
ROCE	-5.36%
ROE	-4.24%
ROE (5Y)	-9.98%
ROIC	-18.74%
ROIC (5Y)	-11.74%
SBC / revenue	4.21%
Tax / revenue	1.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth (QoQ)	39.66%
FCF growth 3Y	60.59%
Gross profit growth	-42.13%
Gross profit growth (Q)	-27.14%
Gross profit growth 3Y	-31.39%
Gross profit growth 5Y	-31.57%
Net income growth years	1
OCF growth (QoQ)	39.66%
OCF growth 3Y	60.45%
Revenue growth	-22.33%
Revenue growth (Q)	-20.37%
Revenue growth (QoQ)	-6.3%
Revenue growth 10Y	4.08%
Revenue growth 3Y	-18.26%
Revenue growth 5Y	-21.9%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$2.6M
EBIT	$-24.6M
EBITDA	$-22M
EPS	$-0.91
FCF per share	$1.78
Financing cash flow	$-2.8M
Free cash flow	$37.5M
Free cash flow minus SBC	$30.1M
Gross profit	$72.1M
Income taxes	$2M
Investing cash flow	$-1.1M
Net cash flow	$33.6M
Net income	$-19.1M
Operating cash flow minus SBC	$30.1M
Operating income	$-24.6M
Revenue	$176.1M
Stock-based compensation	$7.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$21.08
Debt / equity	0.01
Debt / FCF	0.14
Interest coverage	-3,514.57
Long-term assets	$21.2M
Long-term liabilities	$14.5M
Net cash (debt)	$318M
Net cash / market cap	118.78%
Net cash growth	14.58%
Net debt / equity	-0.72
Net debt / FCF	-8.48
Piotroski F-Score	3
Property, plant and equipment	$6.1M
Shareholders' equity	$444.4M
Tangible book value	$433M
Tangible book value per share	$20.54
Total assets	$634.1M
Total cash	$323.4M
Total debt	$5.4M
Total liabilities	$189.7M
WACC	8.31%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.27
Current assets	$612.9M
Current liabilities	$175.1M
Current ratio	3.5
Inventory turnover	0.61
Net working capital	$114.4M
Quick ratio	2.48
Working capital	$437.7M
Working capital turnover	0.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.3%
Dividend yield	0%
Shareholder yield	-1.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-81.42%
10Y return CAGR	-15.49%
10Y total return	-81.42%
150-day SMA	$14.10
15Y price change	-93.6%
15Y return CAGR	-16.74%
15Y total return	-93.6%
1D price change	6.19%
1M price change	-4.02%
1M total return	-4.02%
1W price change	10.37%
1W total return	10.37%
1Y price change	-34.15%
1Y return CAGR	-34.17%
1Y total return	-34.15%
20-day SMA	$11.88
200-day SMA	$14.34
20Y price change	-97.16%
20Y return CAGR	-16.31%
20Y total return	-97.16%
3M price change	-8.25%
3M total return	-8.25%
3Y price change	-8.19%
3Y return CAGR	-2.81%
3Y total return	-8.19%
50-day SMA	$13.04
50-day SMA vs 200-day SMA	50under200
52-week high	$19.24
52-week high date	2025-10-28
52-week low	$11.25
52-week low date	2026-10-22
5Y price change	-86.17%
5Y return CAGR	-32.68%
5Y total return	-86.17%
6M price change	-9.05%
6M total return	-9.05%
All-time high	$28,500.01
All-time high date	1993-07-06
All-time low	$7.08
All-time low date	2025-03-12
Average true range (ATR)	$0.42
Average volume	70.5K
Beta (1Y)	0.74
Beta (2Y)	1.41
Beta (5Y)	0.77
Change from 52-week high	-34.04%
Change from 52-week low	12.8%
Change from all-time high	-99.96%
Change from all-time low	78.95%
Change from open	1.52%
Day's gap	4.6%
Dollar volume	$2M
High price	$12.99
Low price	$12.48
Monthly RSI	40.64
Open price	$12.50
Position in 52-week range	41.18%
Premarket change	2.51%
Premarket close	$11.95
Premarket price	$12.25
Premarket volume	1K
Previous close	$11.95
Price vs 150-day SMA	-10.15%
Price vs 20-day SMA	6.69%
Price vs 200-day SMA	-11.64%
Price vs 50-day SMA	-2.82%
Relative volume	2.21
RSI	57.8
Sharpe ratio	-0.88
Sharpe ratio (3Y)	0.17
Sharpe ratio (5Y)	-0.31
Sortino ratio	-1.13
Sortino ratio (3Y)	0.37
Sortino ratio (5Y)	-0.36
Volume	155.5K
Weekly RSI	43.45
YTD price change	-9.21%
YTD total return	-9.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.4M
Float percentage	91.9%
Shares change (QoQ)	2.74%
Shares change (YoY)	1.3%
Shares held by insiders	1.93%
Shares held by institutions	14.59%
Shares outstanding	21.1M
Short % of shares	2.55%
Short ratio	10.3 days

Deeper analysis on AMRN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AMRN report

Is a complete AMRN research report available?

No complete published report is available for Amarin Corporation plc (AMRN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Amarin Corporation plc (AMRN)

Price

Financial snapshot

Fair-value bridge

Latest news · AMRN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AMRN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AMRN

Frequently asked questions